Wexford Capital LP Danaher Corp Transaction History

Wexford Capital LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$247.06 - $1507.4 $243,601 - $1.49 Million	-986 Reduced 51.73%	920 $238,000
Q2 2022 Aug 15, 2022	BUY	$237.11 - $299.66 $233,790 - $295,464	986 Added 107.17%	1,906 $483,000
Q1 2022 May 13, 2022	SELL	$257.27 - $315.76 $2.57 Million - $3.16 Million	-9,994 Reduced 91.57%	920 $270,000
Q4 2021 Feb 14, 2022	BUY	$292.08 - $329.01 $2.92 Million - $3.29 Million	10,014 Added 1112.67%	10,914 $3.59 Million
Q2 2021 Aug 16, 2021	SELL	$225.08 - $271.69 $3.37 Million - $4.07 Million	-14,987 Reduced 94.33%	900 $242,000
Q1 2021 May 13, 2021	BUY	$212.38 - $245.9 $346,179 - $400,817	1,630 Added 11.43%	15,887 $3.58 Million
Q4 2020 Feb 16, 2021	BUY	$212.5 - $245.46 $3.03 Million - $3.5 Million	14,257 New	14,257 $3.17 Million
Q1 2020 May 18, 2020	SELL	$121.39 - $169.05 $13.2 Million - $18.4 Million	-108,676 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$133.47 - $153.48 $14.5 Million - $16.7 Million	108,676 New	108,676 $16.7 Million

2,432

563M

3.94M

4.11M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $177B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Wexford Capital LP, based on Form 13F filings with the SEC.

Stay updated on Wexford Capital LP with notifications on news.